AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 1 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $12,312,000 | +11.9% | 1,309,753 | -8.9% | 0.00% | 0.0% |
| Q2 2020 | $11,003,000 | -38.4% | 1,438,277 | -50.3% | 0.00% | -50.0% |
| Q1 2020 | $17,873,000 | -45.9% | 2,892,032 | +6.6% | 0.00% | 0.0% |
| Q4 2019 | $33,031,000 | +13.6% | 2,714,099 | +7.8% | 0.00% | 0.0% |
| Q3 2019 | $29,066,000 | +6.4% | 2,516,564 | -7.9% | 0.00% | 0.0% |
| Q2 2019 | $27,305,000 | -24.9% | 2,733,270 | -3.2% | 0.00% | -33.3% |
| Q1 2019 | $36,371,000 | -7.4% | 2,823,826 | +9.3% | 0.00% | -25.0% |
| Q4 2018 | $39,261,000 | -24.7% | 2,584,646 | -0.9% | 0.00% | 0.0% |
| Q3 2018 | $52,164,000 | -1.1% | 2,608,079 | -3.6% | 0.00% | 0.0% |
| Q2 2018 | $52,765,000 | -1.9% | 2,705,882 | +1.4% | 0.00% | -20.0% |
| Q1 2018 | $53,787,000 | +37.0% | 2,669,512 | -9.9% | 0.01% | +66.7% |
| Q4 2017 | $39,261,000 | -13.6% | 2,962,884 | +20.3% | 0.00% | -25.0% |
| Q3 2017 | $45,436,000 | -11.5% | 2,462,684 | -11.7% | 0.00% | -20.0% |
| Q2 2017 | $51,336,000 | -9.7% | 2,789,932 | +10.6% | 0.01% | 0.0% |
| Q1 2017 | $56,876,000 | +13.5% | 2,522,059 | +75.2% | 0.01% | 0.0% |
| Q4 2016 | $50,098,000 | +12.3% | 1,439,693 | -20.9% | 0.01% | +25.0% |
| Q3 2016 | $44,596,000 | +0.9% | 1,819,507 | -1.5% | 0.00% | -20.0% |
| Q2 2016 | $44,204,000 | +16.5% | 1,847,975 | +13.9% | 0.01% | +25.0% |
| Q1 2016 | $37,954,000 | -28.4% | 1,622,135 | -7.6% | 0.00% | -33.3% |
| Q4 2015 | $52,980,000 | +32.4% | 1,755,067 | +74.2% | 0.01% | +20.0% |
| Q3 2015 | $40,020,000 | -31.2% | 1,007,228 | +19.6% | 0.01% | -16.7% |
| Q2 2015 | $58,166,000 | +33.3% | 842,264 | +5.5% | 0.01% | +50.0% |
| Q1 2015 | $43,643,000 | +32.5% | 798,423 | +3.3% | 0.00% | +33.3% |
| Q4 2014 | $32,936,000 | +3.7% | 772,826 | -22.4% | 0.00% | 0.0% |
| Q3 2014 | $31,762,000 | +36.9% | 995,415 | -11.1% | 0.00% | 0.0% |
| Q2 2014 | $23,196,000 | -5.6% | 1,119,465 | -11.8% | 0.00% | 0.0% |
| Q1 2014 | $24,562,000 | +16.9% | 1,269,190 | +24.2% | 0.00% | +200.0% |
| Q4 2013 | $21,011,000 | +75.3% | 1,021,845 | +83.1% | 0.00% | 0.0% |
| Q3 2013 | $11,985,000 | +39.8% | 558,036 | +44.8% | 0.00% | 0.0% |
| Q2 2013 | $8,576,000 | – | 385,389 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 4,060,000 | $46,893,000 | 3.11% |
| Camber Capital Management LP | 4,390,000 | $50,705,000 | 2.67% |
| Palo Alto Investors LP | 3,078,874 | $35,561,000 | 2.37% |
| Permanens Capital L.P. | 407,811 | $4,710,000 | 1.32% |
| Fondren Management LP | 35,000 | $404,000 | 0.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 33,524 | $387,000 | 0.29% |
| BOOTHBAY FUND MANAGEMENT, LLC | 240,000 | $2,772,000 | 0.25% |
| Broadfin Capital, LLC | 100,000 | $1,155,000 | 0.21% |
| FOX RUN MANAGEMENT, L.L.C. | 13,687 | $158,000 | 0.14% |
| Spark Investment Management LLC | 92,200 | $1,064,000 | 0.14% |